Plasma Insulin-like Growth Factor-Binding Protein-2 of Critically Ill Patients Is Related to Disease Severity and Survival

URN to cite this document:: urn:nbn:de:bvb:355-epub-552658
DOI to cite this document:: 10.5283/epub.55265

Mester, Patricia ; Räth, Ulrich ; Popp, Luisa ; Schmid, Stephan

; Müller, Martina ; Buechler, Christa

; Pavel, Vlad

License: Creative Commons Attribution 4.0
PDF - Published Version
(1MB)

Date of publication of this fulltext: 21 Dec 2023 10:54

Alternative links to fulltext:DOI Publisher

Details

Preview

Export bibliographical data

Abstract

Insulin-like growth factor-binding protein (IGFBP)-2 regulates the bioactivity of the anabolic hormone’s insulin-like growth factors, which are decreased in sepsis and contribute to the catabolic status of severely ill patients. The circulating levels of IGFBP-2 in critical illness have been rarely studied; therefore, we evaluated IGFBP-2 plasma levels in patients with systemic ...